Exit 2023 POWER Lymphatics Evaluation Rate the sessions (1 - 5) and offer feedback via your responses. Question Title * 1. Prospective Surveillance in Breast Cancer: Evidence in Action (Binkley) 5 = Excellent 4 = Very Good 3 = Good 2 = Fair 1 = Poor Did not attend Question Title * 2. Comments, Questions? Question Title * 3. Updates from the OR: Lymphedema Prevention and Surgical Management of the Axilla (Murphy) 5 = Excellent 4 = Very Good 3 = Good 2 = Fair 1 = Poor Did not attend Question Title * 4. Comments, Questions? Question Title * 5. ICG Fluorescence Lymphography: What We’ve Learned and Have Yet to Discover (Sevick) 5 = Excellent 4 = Very Good 3 = Good 2 = Fair 1 = Poor Did not attend Question Title * 6. Comments, Questions? Question Title * 7. How effective is our MLD? (Armstrong & Ralph) 5 = Excellent 4 = Very Good 3 = Good 2 = Fair 1 = Poor Did not attend Question Title * 8. Comments, Questions? Question Title * 9. Lymphedema Treatment and Optimal Care Solutions (Tactile Medical) 5 = Excellent 4 = Very Good 3 = Good 2 = Fair 1 = Poor Did not attend Question Title * 10. Comments, Questions? Question Title * 11. Better Together: Creating Strong Relationships with Physicians to Enhance Patient Care (Jordi & Gardner) 5 = Excellent 4 = Very Good 3 = Good 2 = Fair 1 = Poor Did not attend Question Title * 12. Comments, Questions? Question Title * 13. Workshop 1: Treatment Strategies for Head and Neck Lymphedema (Armstrong & Walsh) 5 = Excellent 4 = Very Good 3 = Good 2 = Fair 1 = Poor Did not attend Question Title * 14. Comments, Questions? Question Title * 15. Workshop 2: Treatment for Patients with Genital Lymphedema and/or Pelvic Floor Dysfunction (DiCecco & Hill) 5 = Excellent 4 = Very Good 3 = Good 2 = Fair 1 = Poor Did not attend Question Title * 16. Comments, Questions? Question Title * 17. Workshop 3: Motivational Interviewing (Donahue & Larkin) 5 = Excellent 4 = Very Good 3 = Good 2 = Fair 1 = Poor Did not attend Question Title * 18. Comments, Questions? Question Title * 19. Workshop 4: Treatment of Radiation Fibrotic Changes, Upper Quadrant Dysfunction and Axillary Web Syndrome (Winicour & Roherty) 5 = Excellent 4 = Very Good 3 = Good 2 = Fair 1 = Poor Did not attend Question Title * 20. Comments, Questions? Question Title * 21. Evaluation and Treatment considerations for the Pediatric Lymphedema Patient (Branas) 5 = Excellent 4 = Very Good 3 = Good 2 = Fair 1 = Poor Did not attend Question Title * 22. Comments, Questions? Question Title * 23. Differential Diagnosis: The Importance of LAB Values in the Treatment of Patients with Multifactorial Edema/Lymphedema (Roherty) 5 = Excellent 4 = Very Good 3 = Good 2 = Fair 1 = Poor Did not attend Question Title * 24. Comments, Questions? Question Title * 25. Treatment Flow and Protocols for Patients with Multifactorial Lymphedema (Oberlin) 5 = Excellent 4 = Very Good 3 = Good 2 = Fair 1 = Poor Did not attend Question Title * 26. Comments, Questions? Question Title * 27. Obesity-induced Lymphedema (Thomas) 5 = Excellent 4 = Very Good 3 = Good 2 = Fair 1 = Poor Did not attend Question Title * 28. Comments, Questions? Question Title * 29. Obesity and Phlebolymphedema: What's the Connection (Dean) 5 = Excellent 4 = Very Good 3 = Good 2 = Fair 1 = Poor Did not attend Question Title * 30. Comments, Questions? Question Title * 31. Lymphedema and Wounds (Trock) 5 = Excellent 4 = Very Good 3 = Good 2 = Fair 1 = Poor Did not attend Question Title * 32. Comments, Questions? Question Title * 33. Panel Discussion: Best Practice for Lymphedema 5 = Excellent 4 = Very Good 3 = Good 2 = Fair 1 = Poor Did not attend Question Title * 34. Comments, Questions? Question Title * 35. Were the Course Objectives met? Some were met Most were met All were met I learned more than expected Question Title * 36. If you answered Most or Some, please explain what you thought was missing. Question Title * 37. Was evidence provided to substantiate material presented? Yes No Question Title * 38. If you answered No, please explain Question Title * 39. Were personal experience and observation the primary source of information? Yes No Question Title * 40. If you answered Yes, please explain Question Title * 41. Was a commercial product promoted? Yes No Question Title * 42. If yes, did you feel that the product promotion was the sole purpose of the course? Question Title * 43. Content of course was relevant to my educational needs. 5=Strongly Agree 4=Agree 3=Disagree 2=Strongly Disagree Question Title * 44. Discussion time was adequate and enhanced understanding of the subject. 5=Strongly Agree 4=Agree 3=Disagree 2=Strongly Disagree Question Title * 45. I will apply acquired knowledge to my business. Yes Maybe No Question Title * 46. Overall, how would you rate the 2023 POWER Lymphatics Course? 5=Excellent 4=Very Good 3=Good 2=Fair 1=Poor Question Title * 47. What topics do you think would be beneficial at a future symposium? Question Title * 48. Please list what you enjoyed most about POWER. Question Title * 49. Contact Email (Optional) Done